Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Aug 28, 2024 9:46am
50 Views
Post# 36199159

RE:RE:Good news today and Dear Friend (Dr. George Adams)

RE:RE:Good news today and Dear Friend (Dr. George Adams)Good comment @cardinal revenues will ramp quickly. The company should be cash positive late next year. Once they sell 80-100 units buyout becomes a option. I believe thought that valves create a whole new twist potentially worth Billion ish. Apparently VMS is capable
And Very interesting (=2 Pediatrics Hospital for Sick Children Toronto Canada Oncology, Orthopedics, Neurosurgery) Announcements from these revered hospitals will be forthcoming. 6. The recent grant of a license from Health Canada for VMS+4.0 will now allow us to market this revolutionary advancement in Canada and we have already begun that process. Remember World's Best Specialized Hospitals 2024 https://www.newsweek.com/rankings/worlds-best-specialized-hospitals-2024/pediatrics 36 Pediatrics Seattle Children's Hospital Seattle, WA United States Interesting to see =2 Pediatrics Hospital for Sick Children Toronto Canada Oncology, Orthopedics, Neurosurgery
36 Pediatrics Seattle Children's Hospital Seattle, WA United States Interesting to see =2 Pediatrics Hospital for Sick Children Toronto Canada Oncology, Orthopedics, Neurosurgery
jopatclo wrote: Good news Now remember health Canada has approved us, FDA won’t be far behind. The visionary Dr. G. Adams and Alvira M. have done the long work that had to be done during all these years for Ventripoint to arrive V4.0 Bravo procurement in healthcare is complex . FDA V4.0 and Sales at any time now Insiders know!
Interesting
positive 5. Our staff and associates are energized by interactions with customers and we have many top cardiac centers looking at the VMS+. Announcements from these revered hospitals will be forthcoming. 6. The recent grant of a license from Health Canada for VMS+4.0 will now allow us to market this revolutionary advancement in Canada and we have already begun that process. The Company has submitted an application to the US-FDA and soon will submit for European CE Mark.


<< Previous
Bullboard Posts
Next >>